Cochlear Limited (ASX:COH)
284.83
-0.26 (-0.09%)
Nov 7, 2025, 4:10 PM AEST
Cochlear Revenue
In the fiscal year ending June 30, 2025, Cochlear had annual revenue of 2.34B AUD with 4.81% growth. Cochlear had revenue of 1.17B in the half year ending June 30, 2025, with 11.46% growth.
Revenue
2.34B
Revenue Growth
+4.81%
P/S Ratio
7.95
Revenue / Employee
426.02K
Employees
5,500
Market Cap
18.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.34B | 107.50M | 4.81% |
| Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
| Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
| Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
| Jun 30, 2021 | 1.50B | 177.00M | 13.40% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |
| Pro Medicus | 212.98M |
Cochlear News
- 12 days ago - Brokers throw open $125m Epiminder IPO book; Cochlear in for $10m - The Australian Financial Review
- 3 months ago - Cochlear reports FY results - Seeking Alpha
- 3 months ago - Cochlear Ltd (CHEOF) (FY25) Earnings Call Highlights: Navigating Growth and Challenges - GuruFocus
- 3 months ago - Cochlear CEO depends on built-up inventory as some export licenses lag - CNBC
- 3 months ago - Full Year 2025 Cochlear Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Cochlear Limited 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Cochlear Limited (CHEOF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Cochlear tips higher earnings this year, slower first-half - The Australian Financial Review